Cervical insufficiency: diagnostics and treatment
Keywords:
preterm birth, uterine cervix, pessary, cervical cerclage, progesterone, transvaginal ultrasoundAbstract
WHO reports that every year approximately 15 million children are born prematurely, which makes up 5-18% of all births, depending on a country. The reason for approx. 15% of recurrent miscarriages and premature births is the cervical insufficiency. We define it as painless dilation and effacement of the uterine cervix in the second trimester or early third trimester, which are not accompanied by cramps, vaginal bleeding or rupture of the amniotic sac. The article presents an overview of the methods of diagnostics and cervical insufficiency treatment. The diagnostics mainly involves a maternity interview, gynecological examination and ultrasonography, while the treatment relies on applying the cervical cerclage, pessary or progesterone. Currently, new markers of risk are being looked for a preterm delivery.
Downloads
References
WHO. Preterm birth. Fact sheet No. 363 2013 http://www.who.int/mediacentre/factsheets/fs363/en/# (14.08.2014)
Mangham LJ, Petrou S, Doyle LW, Draper ES, Marlow N. The cost of preterm birth throughout childhood in England and Wales. Pediatrics 2009; 123: e312 – 327.
Shortle B, Jewelewicz R. Cervical incompetence. Fertil Steril 1989, 52, 181-188.
Poon L.C, Savvas M, Zamblera D, Skyfta E, Nicolaides KH. Large loop excision of transformation zone and cervical length in the prediction of spontaneous preterm delivery. BJOG 2012; 119: 692-698.
Vaisbuch E, Romero R, Erez O, i wsp. Clinical significance of early (< 20 weeks) vs. late (20-24 weeks) detection of sonographic short cervix in asymptomatic women in the mid-trimester. Ultrasound Obstet Gynecol 2010; 36: 471-481.
Culpeper N, Cole A, Rowland W. (red). The practice of physick. Londyn. George Sawbridge. 1678: 502-509.
Romero R, Espinoza J, Erez O, Hassan S. The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?. Am J Obstet Gynecol 2006; 1: 1–9.
Sinno A, Usta IM, Nassar AH. A short cervical length in pregnancy: management options. AM J Perinatol 2009; 26: 761-770.
Warren JE, Silver RM. Genetics of the cervix in relation to preterm birth. Smin Perinatol 2009; 33: 308-311.
Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol 2011; 38: 1-9.
Mancuso MS, Owen J. Prevention of preterm birth based on a short cervix: cerclage. Semin Perinatol 2009; 33: 325-333.
Mella MT, Berghella V. Prediction of preterm birth: cervical sonography. Semin Perinatol 2009; 33: 317-324.
Ness A. Prevention of preterm birth based on a short cervix: symptomatic women with preterm labor or premature prelabor rupture of membranes. Semin Perinatol 2009; 33: 343-351.
Crane J.M, Hutchens D. Transvaginal ultrasonographic measurement of cervical length in asymptomatic high-risk women with a short cervical length in the previous pregnancy. Ultrasound Obstet Gynecol; 2011 38: 38-43.
O’Brien JM, Defranco EA, Adair CD, i wsp. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial. Ultrasund Obstet Gynecol 2009; 34: 653-659.
Keeler SM, Kiefer DG, Rust O, i wsp. Comprehensive amniotic fluid cytokine profile evaluation in women with a short cervix: which cytokine(s) correlates best with outcome? Am J Obstet Gynecol 2009; 201: 276.e1-276.e6.
Kiefer DG, Keeler SM, Rust O, i wsp. Amniotic fluid inflammatory score is associated with pregnancy outcome in patients with mid trimester short cervix. Am J Obstet Gynecol 2012; 206: 68.e1-68.e6.
Vaisbuch E, Hassan SS, Mazaki-Tovi S, i wsp. Patients with an asymptomatic short cervix (15 mm) have a high rate of subclinical intraamniotic inflammation: implications for patient counseling. Am J Obstet Gynecol 2010; 202: 433.e1-433.e8.
Himaya E, Rhalmi N, Girard M, i wsp. Midtrimester intra-amniotic sludge and the risk of spontaneous preterm birth. Am J Perinatol 2011; 28: 815-820.
Hernandez-Andrade E, Romero R, Korzeniewski SJ, i wsp. Cervical strain determined by ultrasound elastography and its association with spontaneous preterm delivery. J Perinat Med 2014; 42: 159-169.
RCOG. Green-top Guidline. Cervical Cerclage. No. 60. 2011.
McDonald IA. Suture of the cervix for inevitable miscarriage. J Obstet Gynaecol Br Emp 1957; 64: 346-353.
Shirodkar VN. A new method of operative treatment for habitual abortions in the second trimester of pregnancy. Antiseptic 1955; 52: 299-300.
Ades A, May J, Cade TJ, Umstad MP. Laparoscopic transabdominal cervical cerclage: A 6-year experience. Aust N Z J Obstet Gynecol 2014; 54: 117-120.
Tulandi T, Alghanaim N, Hakeem G, Tan X. Pre and post-conceptional abdominal cerclage by laparoscopy or laparotomy. J Minim Invasive Gynecol. http://dx.doi.org/10.1016/j.jmig.2014.05.015 (4.06.2014)
Goulding E, Lim B. McDonald transvaginal cervical cerclage since 1957: from its roots in Australia into worldwide contemporary practice. BJOG 2014; 121: 1107.
Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: meta-analysis. Obstet Gynecol 2011; 117: 663-671.
Naz H, Sultana A, Baqai Z. Beneficial effect of cervical cerclage in preventing pregnancy loss. J Surgery Pakistan 2012; 17: 112-115.
Brown R, Gagnon R, Delisle MF. Cervical insufficiency and cervical cerclage. J Obstet Gynaecol Can 2013; 35: 1115-1127.
Antczak-Judycka A, Sawicki W, Śpiewaniewicz B, Cendrowski K. Porównanie skuteczności leczenia szwem szyjkowym oraz pessarium kołnierzowym szyjki macicy u ciężarnych z niewydolnością cieśniowo-szyjkową i zagrażającym porodem przedwczesnym. Ginekol Pol 2003; 74: 1029-1036.
Cross RG. Treatment of habitual abortion due to cervical incompetence. Lancet 1959; 2: 127.
Vitsky M. Simple treatment of the incompetent cervical os. Am J Obstet Gynecol 1961; 81: 1194 – 1197.
Cannie MM, Dobrescu O, Gucciardo L, i wsp. Arabin cervical pessary in women at high risk of preterm birth: a magnetic resonance imaging observational follow-up study. Ultrasound Obstet Gynecol 2013; 42: 426-433.
Herbich Michael Sp. z o.o. http://www.herbich.pl/site/pessars (15.08.2014)
Goya M, Pratcorona L, Merced C, i wsp. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012; 379: 1800-1806.
Sieroszewski P, Jasiński A, Perenc M, Banach R, Oszukowski P. The Arabin pessary for the treatment of threatened mid-trimester miscarriage or premature labour and miscarriage: a case series. J Matern Fetal Neonatal Med 2009; 22: 469-472.
Jalinik K, Hamela-Olkowska A, Teliga-Czajkowska J, Czajkowski K. Ocena porównawcza skuteczności szwu szyjkowego i pessarium w leczeniu niewydolności cieśniowo-szyjkowej w ciąży. Med Wieku Rozwoj 2003; 7; supp 1: 181 – 185.
Alfirevic Z, Owen J, Carreras Moratonas E, Sharp AN, Szychowski JM, Goya M. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol 2013; 41: 146-151.
Novy M, Haymond J, Nichols M. Shirodkar cerclage in a multifactorial approach to the patient with advanced cervical changes. Am J Obstet Gynecol 1990; 162: 1412 – 1420.
Conde-Agudelo A, Romero R, Nicolaides K, i wsp. Vaginal progesterone versus cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, singleton gestation, and previous preterm birth: a systematic review and indirect comparison meta-analysis. Am J Gynecol 2013; 208: 42.e1–42.e18.
van Os MA, van der Ven JA, Kleinrouweler CE, i wsp. Preventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P study. BMC Pregnancy Childbirth 2011; 11: 77.
Hassan SS., Romero R, Vidyadhari D, i wsp. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-control trial. Ultrasound Obstet Gynecol 2011; 38: 18-31.
Brubaker SG, Gyamfi C. Prediction and prevention of spontaneous preterm birth in twin gestations. Semin Perinatol 2012; 3: 190-194.
Conde-Agudelo A, Romero R. Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2010; 23: 1365-1376.
Fox NS, Saltzman DH, Klauser CK, Peress D, Gutierrez CV, Rebarber A. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol 2009; 201: 313.e1-313.e5.
Honest H, Forbes CA, Durée KH, i wsp. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modeling. Health Technol Assess 2009; 13: 1-627.
Liem S, Schuit E, Hegeman M, i wsp. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentere, open-label randomized controlled trial. Lancet 2013; 382: 1341-1349.
Klein K, Rode L, Nicolaides KH, Klampl-Bettelheim E, Tabor A for the PREDICT Group. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis. Ultrasound Ostet Gynecol 2011; 38: 281-287.
Durnwald CP, Momirova V, Rouse DJ. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17 alpha hydroxyprogesterone caproate. J Matern Fetal Neonatal Med 2010; 23: 1360-1364.
Rode L, Klein K, Nicolaides KH, Klampl-Bettelheim E, Tabor A for the PREDICT Group. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011; 38: 272-280.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
